CHD2 Gene Epileptic Encephalopathy Childhood-Onset NGS Genetic DNA Test
Introduction
The CHD2 Gene Epileptic Encephalopathy Childhood-Onset NGS Genetic DNA Test is a groundbreaking diagnostic tool designed to identify genetic mutations associated with childhood-onset epilepsy. This test employs Next Generation Sequencing (NGS) technology, offering a detailed analysis of the CHD2 gene, which plays a critical role in neurological function.
What the Test Measures
This test specifically detects mutations in the CHD2 gene that may lead to epileptic encephalopathy, a severe form of epilepsy characterized by frequent seizures and developmental delays. By analyzing the genetic makeup, healthcare providers can gain insights into the underlying causes of the condition.
Who Should Consider This Test
Parents and guardians should consider this test for children exhibiting symptoms such as:
- Frequent seizures
- Developmental delays
- Unexplained neurological symptoms
Additionally, those with a family history of epilepsy or neurological disorders may find this test beneficial for early diagnosis and management.
Benefits of Taking the Test
- Provides a definitive diagnosis for childhood-onset epilepsy.
- Helps in understanding the genetic basis of the condition.
- Guides treatment options and management strategies.
- Offers valuable information for family planning and genetic counseling.
Understanding Your Results
Results from the CHD2 Gene Epileptic Encephalopathy test typically take 3 to 4 weeks. A genetic counselor or neurologist will assist in interpreting the results, explaining what the findings mean for your child’s health and future.
Test Pricing
| Price Type | Price (KSh) |
|---|---|
| Discount Price | 40,000 |
| Regular Price | 56,000 |
Book Your Test Today!
We have branches across Kenya and offer home sample collection services for your convenience. To schedule your CHD2 Gene Epileptic Encephalopathy Childhood-Onset NGS Genetic DNA Test, please call or WhatsApp us at +254711564616.
